Noriaki Tokuda

Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial

Michiel S. van der Heijden, Matthew D. Galsky, Yohann Loriot et al. · The Lancet Oncology · 2020 · 498 citations · Full text

Medicine, Oncology, Pharmacology +14

Collecting Duct (Bellini Duct) Renal Cell Carcinoma: A Nationwide Survey in Japan

Noriaki Tokuda, Seiji Naito, Osamu Matsuzaki et al. · The Journal of Urology · 2006 · 188 citations

Medicine, Surgery, Urology +12

Late Recurrence of Renal Cell Carcinoma: Retrospective and Collaborative Study of the Japanese Society of Renal Cancer

Noriomi Miyao, Seiji Naito, Seiichiro Ozono et al. · Urology · 2010 · 100 citations

Medicine, Oncology, Urology +12

1,25-Dihydroxyvitamin D3 Stimulates Phagocytosis but Suppresses HLA-DR and CD13 Antigen Expression in Human Mononuclear Phagocytes

Noriaki Tokuda, Robert B. Levy · Experimental Biology and Medicine · 1996 · 81 citations

Life Sciences, Cell Biology, Immunology +13

1,25-Dihydroxyvitamin D3 down-regulation of HLA-DR on human peripheral blood monocytes.

Noriaki Tokuda, Nobuyuki Mizuki, Masanori Kasahara et al. · PubMed · 1992 · 53 citations

Life Sciences, Cell Biology, Immunology +13